|
OcuCure Therapeutics |
|
OcuCure Therapeutics, Inc. is an ophthalmic pharmaceutical company developing new proprietary drugs. The company’s lead compound has been formulated as a topical eye drop for both Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). AMD and DR are leading causes of blindness in developed countries. Additionally, the lead compound has potential for use as a prophylactic. OcuCure Therapeutics, Inc. |